| Document Date: 2009-03-31 14:50:57
Open Document File Size: 171,59 KBShare Result on Facebook
Company Merck & Co. Inc. / Seasonal Allergic Rhinitis Treatment Group / / Continent North America / Europe / / Country United States / / Currency pence / / Event FDA Phase / Product Recall / Product Issues / / IndustryTerm food ingestion / food / / MedicalCondition bronchospasm / vasculitis / inflammatory process / chronic / Churg-Strauss syndrome / perennial allergic rhinitis / cirrhosis / nasal congestion / itching / nasal obstruction / status asthmaticus / Renal Insufficiency / pulmonary / muscle contraction / allergic rhinitis / seasonal allergic rhinitis / hepatitis / rash / bronchoconstriction / eosinophilia / Hepatic Insufficiency / asthma / / Person AM PEFR / / Position physician / probe substrate representative / representative / General / Prime Minister / / Product fluticasone propionate / loratadine / CHEWABLE TABLETS / estradiol / prednisolone / theophylline / paclitaxel / digoxin / flunisolide / ketoconazole / SINGULAIR / prednisone / triamcinolone acetonide / erythromycin / repaglinide / fexofenadine / albuterol / mannitol / rifampin / rosiglitazone / fluconazole / / Technology Pharmacokinetics / Pharmacodynamics / stem cells / /
SocialTag |
SINGULAIR - montelukast sodium granule SINGULAIR - montelukast sodium tablet, chewable SINGULAIR - montelukast sodium tablet, film coated Merck & Co., Inc[removed]SINGULAIR®